Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland

Metformin Disrupts Crosstalk between G Protein–Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth

Krisztina Kisfalvi, Guido Eibl, James Sinnett‐Smith et al. · Cancer Research · 2009 · 315 citations · Full text

Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi et al. · Cancer Prevention Research · 2010 · 311 citations · Full text

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

John T. Lear, Michael R. Migden, Karl D. Lewis et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 189 citations · Full text

Data quality at the Icelandic Cancer Registry: Comparability, validity, timeliness and completeness

Lára G. Sigurðardóttir, Jón G. Jónasson, Sigrun Stefansdottir et al. · Acta Oncologica · 2012 · 157 citations · Full text

Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway

Chao Niu, Zhiwei Chen, Kyoung‐Tae Kim et al. · Autophagy · 2019 · 143 citations · Full text